AI assistant
SVBI — Proxy Solicitation & Information Statement 2026
May 29, 2026
51921_rns_2026-05-29_82298fb6-dde6-4de5-8527-88015bddcb4f.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
SciVision Biotech Inc.
2026 General Shareholders' Meeting
The 2026 General Shareholders' Meeting (the "Meeting") of SciVision Biotech Inc. (the "Company") will be convened at 09:00 a.m., Monday, June, 29, 2026 (the time for shareholders' registration starts at 8:30a.m. at the meeting venue) at No. 12, Fuxing 4th Road, Qianzhen District, Kaohsiung City (Atrium Saloon, Building A, South District, Kaohsiung Software Technology Park)
Convene Format: Physical Shareholders' Meeting
- The agendas for the Meeting are as follows:
I. Reports
(1) 2025 Business Report.
(2) Audit Committee's Review Report on 2025 Financial Statements.
(3) 2025 Remuneration for Employees and Directors.
(4) Excursion Report on the 3rd Domestic Unsecured Convertible Corporate Bond.
(5) Appropriation of 2025 Earnings and Cash Distribution.
(6) Execution of Share Repurchase by the Company.
II. Ratifications
(1) Ratification of 2025 Business Report and Financial Statements.
(2) 2025 Earnings Distribution Proposal.
III. Elections matters
(1) Election of 9 Directors (Including 3 Independent directors).
IV. Discussions
(1) Lifting Non-Competition Restrictions for Newly Elected Directors.
(2) Proposed Partial Amendments to the "Articles of Incorporation".
V. Extempore Motions
-
Shareholders can go to the Company's website > Investor Relations > Shareholder Services (view at https://www.scivision.com.tw/) to view the "2026 General Shareholders' Meeting Video" after the Shareholders' Meeting.
-
The Company intends to appropriate cash dividends of approximately NT$1.90885091. per share (earnings appropriation of NT$1.90885091 per share). As authorized by the Board of Directors, the ex-dividend date is set for May 5, 2026, and payment will be made on May 29, 2026.
-
If there exist any matters that shall be itemized in the causes and the essential contents thereof shall be explained pursuant to Article 172 of the Company Law, the essential contents can be found at the Market Observation Post System (http:// mops.twse.com.tw). Please log into said website, and click
"electronic books", key in the Year "2026," select the code of the Company "1786," and read references related to the shareholders' meeting.
-
In accordance with section 165 of the Companies Act, the transfer of shares was suspended from May 1, 2026 to June 29, 2026
-
The shareholder's voting power of this annual shareholders' meeting may be exercised by way of electronic transmission, and the exercising period will be from May 30, 2026 through June 26, 2026. Please log in the "Stockvote" established by Taiwan Depository & Clearing Corporation at https://stockservices.tdcc.com.tw.
-
The institution for tallying and verifying proxy forms of 2026 general shareholders' meeting is Stock Registration Department, HORIZON SECURITIES CO., LTD.
Board of Directors
SciVision Biotech Inc.